The Physician and Sportsmedicine
Menubar Home Journal Personal Health Resource Center CME Advertiser Services About Us

Oral Creatine Supplementation

Separating Fact From Hype

Mark S. Juhn, DO

THE PHYSICIAN AND SPORTSMEDICINE - VOL 27 - NO. 5 - MAY 1999


In Brief: Many athletes—especially those participating in sports that emphasize strength—are taking oral creatine. Creatine supplements appear to enhance performance in repeated short bursts of stationary cycling and weight lifting, but the data on running, swimming, and single cycle sprints are not convincing of an ergogenic effect. Commonly reported side effects include muscle cramping, GI disturbances, and renal dysfunction, but creatine's effect on the heart, brain, reproductive organs, and other organs has yet to be determined. Comprehensive studies with larger samples and crossover design are needed. If patients decide to take oral creatine, physicians need to provide guidance for proper dosing as well as education about potential harmful effects.

Consumption of synthetically manufactured creatine by athletes and bodybuilders attempting to enhance athletic performance has become very popular. A surge in use began in 1992, when Harris et al (1) showed that oral supplementation with high doses of creatine resulted in a 20% increase in skeletal muscle creatine concentration. Although no claims could be made with regard to its effect on athletic performance, companies were quick to market the ergogenic potential of this legal substance. Creatine is not banned by the National Collegiate Athletic Association or the International Olympic Committee.

How Creatine Is Metabolized

Creatine is a nitrogenous amino acid compound found naturally in skeletal muscle, heart, brain, testes, retina, and other tissues (2), In skeletal muscle, approximately one-fourth exists as free creatine and three-fourths as phosphocreatine (PCr) (3,4). Creatine is synthesized primarily by the liver, kidneys, and pancreas at a rate of 1 to 2 g/day (3-5). An additional 1 to 2 g/day is obtained in the diet, mainly from fish and meats (3,6). Excretion of creatine by the kidneys at a rate of 1 to 2 g/day is via irreversible conversion to creatinine in skeletal muscle (3). The reader should use caution not to confuse creatine with creatinine.

Total creatine is the sum of free creatine and phosphocreatine (PCr). Both types play important roles in anaerobic adenosine triphosphate (ATP) production during maximal anaerobic burst-type exercise via the creatine kinase system (4,7) (figure 1: not shown). Creatine and PCr exist in a reversible equilibrium in skeletal muscle (4,7,8). During intense muscle contraction, the flux in the forward direction increases, which rapidly produces more ATP for energy, anaerobically (4,7,9). The PCr reaction contributes significantly to ATP resynthesis for about 10 to 20 seconds of maximal exercise. This is followed by a proportionate increase in other pathways of ATP resynthesis, such as anaerobic glycolysis or aerobic oxidation of carbohydrate and fat (9).

Creatine supplementation can increase muscle PCr concentration by 6% to 16% (1,10-14), theoretically enhancing ATP turnover during maximal exercise. Additionally, creatine supplementation may enhance resynthesis of PCr during rest periods between repeated short bouts of exercise (15), though a recent study (14) did not support this theory. There is also some evidence that prolonged creatine supplementation increases myofibrillar protein synthesis, which results in muscle accretion (16,17), a controversial topic that will be discussed later.

In summary then, oral creatine supplementation may be ergogenic for the following reasons:

  • Higher PCr concentration in skeletal muscle, allowing for enhanced anaerobic ATP production during maximal exercise;
  • Enhanced resynthesis of PCr during recovery periods between short bouts of maximal exercise; and
  • Possible muscle accretion.

It should be noted that the PCr reaction is anaerobic (4,7), meaning that oral creatine supplementation is potentially ergogenic only for activity that has a high anaerobic component, not for endurance activity (18,19). The possibility exists, however, that creatine may be ergogenic for endurance events that involve intermittent bursts of anaerobic activity.

Usual Dosage

The typical creatine supplementation protocol begins with a loading dose of 20 g/day (or 0.3 g/kg) for 5 days, followed by a "maintenance" dose of 2 g/day (or 0.03 g/kg) (12), though the maintenance dose is often unnecessarily exceeded (20). Although a 5-day loading period is typical, 2 days of loading has been shown to yield similar muscle creatine concentration and performance results (14). Without loading, 3 g/day for 28 days results in muscle creatine concentrations similar to 5 days of loading (12).

A study by Green et al (21) found that the addition of a carbohydrate solution (90 g four times daily during the loading phase) further enhanced the increase in muscle creatine concentration relative to taking creatine alone. Based on this study, the combination of creatine with sports drinks has become popular.

It is important to note, however, that skeletal muscle has a creatine storage capacity of 150 to 160 mmol/kg (normal is 125 mmol/kg) (1,10), which makes oversupplementation futile. This is important information for those who think that more is better. Any excess creatine ingestion will not further increase muscle creatine but will simply increase urinary creatine and creatinine excretion.

Muscle concentrations of creatine and PCr return to baseline levels approximately 28 days after discontinuing creatine supplementation (13,22).

Does Creatine Aid Performance?

In controlled laboratory studies, oral creatine supplementation has been shown to be ergogenic in repeated stationary cycling sprints (23-28), weight lifting (13,26,27,29), repetitive sets of muscle contractions such as knee extensions (14,30), and kayak ergometry (31). However, the media and even some in the scientific community often extrapolate these studies to a much broader generalization regarding athletic performance, seemingly omitting mention of many studies that do not demonstrate an ergogenic effect. This can be misleading for the athlete and clinician alike.

Common misconceptions. There are two common misconceptions about creatine's ergogenic potential. The first is a gross generalization that creatine supplementation is ergogenic for all types of "sprinting," including running, swimming, and cycling. The fact is, the literature has shown reasonable support for an ergogenic benefit only in repeated bouts of stationary cycling sprints in a laboratory setting (table 1) (23-28). And unanimity is lacking even here, as there are several studies (22,32-34) of repeated cycling sprints that did not demonstrate an ergogenic effect.


Table 1. Effect of Oral Creatine Supplementation on Specific Activities

Activity Summary of Studies Comments
Stationary cycling sprints Several studies support an ergogenic effect in repeated sprints but are not convincing for single sprints Field studies with bicycles on a track are needed to simulate actual competition
Running sprints (repeated or single) Conflicting results regarding performance enhancement Speculation is that weight gain offsets any potential benefit
Swimming sprints (repeated or single) Conflicting results regarding performance enhancement Speculation is that weight gain offsets any potential benefit
Weight lifting Some evidence of an ergogenic effect Whether creatine supplementation truly increases muscle synthesis is being investigated. Creatine-induced weight gain may make true double-blindness difficult to achieve

As for creatine's effect on running sprints and swimming sprints (35), more studies (36-40) have demonstrated no benefit with supplementation than have demonstrated a benefit (41). (Some studies produced mixed results: Both Bosco et al (42) and Peyrebrune et al (43) found one protocol to show no benefit and one protocol to show a benefit, while Grindstaff et al (44) found no benefit in two swimming heats and some benefit in one.)

It is speculated that the weight gain from water retention that occurs with creatine supplementation (12,13) may impede performance in runners and swimmers. The effect of weight gain on performance may not be as significant in a weight-supported activity such as stationary cycling or weight lifting. Also, the cycling studies are performed on stationary cycle ergometers, not on bicycles on a track or road. This has led some to question whether creatine is truly ergogenic outside of a laboratory. In general, the vague term "sprinting" should be avoided when discussing creatine's ergogenic potential.

The second common misconception is that creatine supplementation is beneficial in a single timed event, such as a single sprint. The fact is that, even with stationary cycling, creatine has not been shown to enhance single-event performance (25,45-47). Again, the strongest support for the ergogenic potential of creatine supplementation is in repeated maximal bursts of activity, specifically 6- to 30-second bouts of stationary cycling with 20 seconds to 5 minutes of rest between bouts (23-28). However, some multiple-bout studies (24,25,27) did demonstrate an improvement in the first bout, which can be construed as single-bout performance.

Because the evidence does not strongly support an ergogenic effect of oral creatine on single-sprint activity and because most competition involves single timed events rather than repetitive burst activity, some have expressed skepticism that creatine can truly help athletic performance. The argument can be made, however, that athletes in sports such as football, which involves repeated bursts of maximal exercise, may gain an ergogenic effect from creatine supplementation. On the other hand, players need to consider the possible detriment of weight gain, though some athletes may find the weight gain desirable, depending on the sport and position they play.

Conflicting results. The variable results in creatine studies are difficult to explain but may be due to study design, author bias, or subject variability. Very few studies incorporated a crossover design, in which the control group becomes the experimental group and vice versa after a washout period. Crossover designs reduce the sample size required and reduce the chances of a type 2 statistical error (an acceptance of the null hypothesis when in fact it is false).

Author bias may also contribute to the different conclusions seen. According to disclosure statements accompanying the articles, several studies were funded by grants from sport supplement companies or have one or more authors who serve as consultants for such companies (26,27,44). Such affiliations would, of course, not affect results, but they may unintentionally influence the discussion and ultimately the authors' conclusions. Finally, a simple yet very plausible hypothesis to explain conflicting study results is subject variability.

Water Mass or Muscle Mass?

Creatine supplementation results in weight gain, from 0.5 to 1.6 kg during the 5-day loading phase (15,25,26,29,32,33,38,47), and even more with prolonged use (13,27). The weight gain is initially due to water retention (12,13). After 1 year of use, muscle accretion may occur (17), although this is unproved and still under study.

Several studies (13,26,27,29) have demonstrated an ergogenic effect of creatine supplementation in weight lifting. Weight gain, however, is noted even after 1 to 2 days of creatine loading, which is too short a time for appreciable muscle accretion to occur. Furthermore, it is possible that despite investigators' efforts to maintain double-blindness, the weight gain experienced by those in the creatine group can result in a placebo effect of feeling "stronger."

Further study is needed to determine if oral creatine supplementation per se enhances muscle accretion and truly increases strength. However, even without muscle accretion, the ergogenic effect observed may be due to enhanced ATP turnover as discussed previously.

Potential Adverse Effects

Adverse effects of oral creatine supplementation have not been extensively studied, though concerns have been prevalent in the media and training rooms. In the United States, creatine is considered a dietary supplement. Therefore, in accordance with the Dietary Supplement Health and Education Act of 1994 (48), claims regarding performance and safety do not need to be substantiated by the US Food and Drug Administration (FDA).

Muscle cramping. It is common to hear reports from athletic trainers about muscle cramping or strains in athletes taking creatine. Since water retention occurs with creatine supplementation (12,13), it is speculated that this effect increases skeletal muscle compartment pressure, leading to the risk of muscle dysfunction. In some studies that have evaluated performance (11,13,14,27,44), none of the subjects experienced muscle cramping. However, such studies had sample sizes of 25 or fewer, which is suboptimal for comprehensive statistical analysis.

To elaborate, if a side effect is present in 50% of an experimental group versus 30% of a control group, and the researcher wishes to achieve a statistical significance level of 0.05 with 80% power, then a sample size of 146 (73 in each group) is needed (49). The sample size required is much larger if 90% power is the goal, or if the difference between groups is less, such as 40% versus 30%.

In one survey of 52 male collegiate athletes (20), muscle cramping was reported by 25% of those who took creatine. However, this was not a controlled study, and, in most cases, such complaints did not cause the athlete voluntarily to stop taking creatine. While theoretical concerns and anecdotal reports abound, randomized double-blind studies with larger numbers of subjects and crossover design are needed to more accurately assess this controversial aspect.

Gastrointestinal effects. Diarrhea and gastrointestinal pain have also been reported anecdotally. Authors of several performance studies (11,13,14,27,44) noted that none of their subjects experienced gastrointestinal symptoms of any kind, but, again, sample sizes were extremely small (fewer than 12 in the experimental group). Since the average diet includes 1 to 2 g of creatine daily, it may be reasonable to assume that a loading dose of 20 g daily for 5 days is excessive for some people's digestive systems.

Renal dysfunction. Anecdotal reports and two published case reports (50,51) of renal dysfunction in subjects taking creatine have raised concern about the effects of creatine supplementation on the kidneys. Short-term (5-day) creatine supplementation does not appear to impair function in the healthy kidney (52). However, supplementation significantly increases the urinary creatine excretion rate, as much as 90-fold during the loading phase (13,52), and whether this has long-term adverse effects is unclear. Urinary creatinine also increases, but to a much lesser degree (12-14,53). Currently, creatine supplementation should not be used by people with preexisting renal disease or by those with a potential for renal dysfunction (eg, those who have diabetes).

Dehydration. There is anecdotal concern that the water retention resulting from creatine supplementation can increase the risk of dehydration via fluid shifts into the skeletal muscle cells (intracellular water retention). While an increased risk of dehydration has not been proven, most creatine manufacturers advocate proper hydration while taking creatine, theoretically to reduce this chance.

Unstudied Potential Effects

Creatine is naturally found in many other places in the body, including the heart, brain, and testicles (2). The fact that possible side effects in these areas receive less attention than muscle cramping and gastrointestinal effects is surprising and of concern. It is unknown, for example, what effect oral creatine supplementation has on creatine concentration in the heart, brain, and reproductive organs. Furthermore, oral creatine supplementation results in the attenuation or suppression of endogenous creatine synthesis by the liver (13), and the long-term effects of this on the liver or other organ systems are not known. In addition, creatine is found and synthesized in the testes (54,55), and animal studies have shown that creatine is involved in sperm metabolism (56).

Other potential areas of concern have been addressed in a recent critical review (57), which is summarized in table 2 (not shown) (2,11-13,17,27,38,52,53,55,56,58-64). One notable area that remains unstudied is the pediatric population, perhaps the most susceptible population when it comes to ergogenics and athletic performance. Clearly, human studies evaluating the effects of oral creatine supplementation beyond just muscle cramping and diarrhea are indicated.

The FDA has officially logged 32 complaints regarding people who used creatine (65). These complaints include seizure, cardiac arrhythmia, cardiomyopathy, deep venous thrombosis, rhabdomyolysis, and death. Thus far, no conclusions linking these reports to creatine supplementation have been made. A well-publicized case series of three wrestlers who died after taking severe dehydration measures implicated creatine as a contributor, but this claim was not supported by an investigation by the Centers for Disease Control and Prevention (66). In addition, ethical and legal issues need to be resolved (see "Creatine: Ethical and Medicolegal Issues," below).

Advice for Patients

Physicians will continue to encounter patients who insist on using creatine. When this occurs, informing patients of the following would be a reasonable start:

  • Creatine may or may not help patients achieve what they want.
  • After the loading phase of 20 g daily (or 0.3 g/kg) for 2 to 5 days, maintenance should be 2 g/day, or 0.03 g/kg. Any extra is simply urinated out.
  • Creatine users will gain weight because of water retention, which may slow them down.
  • Creatine is not regulated by the FDA, and its safety profile is not established.
  • Patients take creatine at their own risk.

It is up to the physician whether or not to monitor patients with regular laboratory tests. A baseline set of renal and liver function lab values would be advisable, as would a screening physical examination.

Supplemental Information

There is evidence that oral creatine supplementation enhances performance in repeated short bouts of stationary cycling in a laboratory setting. The most accepted hypothesis is that enhanced ATP turnover as a result of greater muscle PCr concentration after supplementation enhances muscle contractility. However, the data on creatine supplementation and single sprints of any kind do not support an ergogenic effect. Additionally, the evidence that creatine improves running and swimming performance is not convincing, perhaps because of weight gain from water retention. Also, it remains to be seen if long-term creatine supplementation enhances muscle accretion. Finally, creatine has not been shown to be ergogenic outside the laboratory setting.

Commonly reported adverse effects of creatine supplementation include muscle cramping and gastrointestinal disturbances, but studies with larger sample sizes are needed to identify the scope of the problem. The greater concern lies in the unknown effects of creatine supplementation on various organ systems, particularly the kidneys, liver, heart, brain, and reproductive organs.

Though physicians can educate patients about oral creatine use, the decision on supplementation will ultimately be made by the patient. Physicians, though, can provide valuable guidance.

References

  1. Harris RC, Soderlund K, Hultman E: Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Colch) 1992;83(3):367-374
  2. Wallimann T, Hemmer W: Creatine kinase in non-muscle tissues and cells. Mol Cell Biochem 1994;133-134(Apr-May):193-220
  3. Walker JB: Creatine: biosynthesis, regulation, and function. Adv Enzymol Relat Areas Mol Biol 1979;50:177-242
  4. Wallimann T, Wyss M, Brdiczka D, et al: Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992;281(pt 1):21-40
  5. Loike JD, Somes M, Silverstein SC: Creatine uptake, metabolism, and efflux in human monocytes and macrophages. Am J Physiol 1986;251(1 pt 1):C128-C135
  6. Balsom PD, Soderlund K, Ekblom B: Creatine in humans with special reference to creatine supplementation. Sports Med 1994;18(4):268-280
  7. Bessman SP, Geiger PJ: Transport of energy in muscle: the phosphorylcreatine shuttle. Science 1981;211(4481):448-452
  8. Sahlin K, Harris RC, Hultman E: Resynthesis of creatine phosphate in human muscle after exercise in relation to intramuscular pH and availability of oxygen. Scand J Clin Lab Invest 1979;39(6):551-558
  9. Hultman E, Greenhaff PL, Ren JM, et al: Energy metabolism and fatigue during intense muscle contraction. Biochem Soc Trans 1991;19(2):347-353
  10. Casey A, Constantin-Teodosiu D, Howell S, et al: Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. Am J Physiol 1996;271(1 pt 1):E31-E37
  11. Gordon A, Hultman E, Kaijser L, et al: Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res 1995;30(3):413-418
  12. Hultman E, Soderlund K, Timmons JA, et al: Muscle creatine loading in men. J Appl Physiol 1996;81(1):232-237
  13. Vandenberghe K, Goris M, Van Hecke P, et al: Long-term creatine intake is beneficial to muscle performance during resistance training. J Appl Physiol 1997;83(6):2055-2063
  14. Vandenberghe K, Van Hecke P, Van Leemputte M, et al: Phosphocreatine resynthesis is not affected by creatine loading. Med Sci Sports Exerc 1999;31(2):236-242
  15. Greenhaff PL, Bodin K, Soderlund K, et al: Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 1994;266(5 pt 1):E725-E730
  16. Ingwall JS, Morales MF, Stockdale FE, et al: Creatine: a possible stimulus for skeletal and cardiac muscle hypertrophy. Recent Adv Stud Cardiac Struct Metab 1975;8:467-481
  17. Sipila I, Rapola J, Simell O, et al: Supplementary creatine as a treatment for gyrate atrophy of the choroid retina. N Engl J Med 1981;304(15):867-870
  18. Balsom PD, Harridge SD, Soderlund K, et al: Creatine supplementation per se does not enhance endurance exercise performance. Acta Physiol Scand 1993;149(4):521-523
  19. Terrillion KA, Kolkhorst FW, Dolgener FA, et al: The effect of creatine supplementation on two 700-m maximal running bouts. Int J Sport Nutr 1997;7(2):138-143
  20. Juhn MS, O'Kane JW, Vinci DM: Oral creatine supplementation in male collegiate athletes: a survey of dosing habits and side effects. J Am Diet Assoc 1999;99(5):593-595
  21. Green AL, Hultman E, Macdonald IA, et al: Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am J Physiol 1996;271(5 pt 1):E821-E826
  22. Febbraio MA, Flanagan TR, Snow RJ, et al: Effect of creatine supplementation on intramuscular TCr, metabolism and performance during intermittent, supramaximal exercise in humans. Acta Physiol Scand 1995;155(4):387-395
  23. Balsom PD, Ekblom B, Soderlund K, et al: Creatine supplementation and dynamic high-intensity intermittent exercise. Scand J Med Sci Sports 1993;3:143-149
  24. Birch R, Noble D, Greenhaff PL: The influence of dietary creatine supplementation on performance during repeated bouts of maximal isokinetic cycling in man. Eur J Appl Physiol 1994;69(3):268-276
  25. Dawson B, Cutler M, Moody A, et al: Effects of oral creatine loading on single and repeated maximal short sprints. Aust J Sci Med Sport 1995;27(3):56-61
  26. Earnest CP, Snell PG, Rodriguez R, et al: The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand 1995;153(2):207-209
  27. Kreider RB, Ferreira M, Wilson M, et al: Effects of creatine supplementation on body composition, strength, and sprint performance. Med Sci Sports Exerc 1998;30(1):73-82
  28. Prevost MC, Nelson AG, Morris GS: Creatine supplementation enhances intermittent work performance. Res Q Exerc Sport 1997;68(3):233-240
  29. Volek JS, Kraemer WJ, Bush JA, et al: Creatine supplementation enhances muscular performance during high-intensity resistance exercise. J Am Diet Assoc 1997;97(7):765-770
  30. Maganaris CN, Maughan RJ: Creatine supplementation enhances maximum voluntary isometric force and endurance capacity in resistance trained men. Acta Physiol Scand 1998;163(3):279-287
  31. McNaughton LR, Dalton B, Tarr J: The effects of creatine supplementation on high-intensity exercise performance in elite performers. Eur J Appl Physiol 1998;78(3):236-240
  32. Barnett C, Hinds M, Jenkins DG: Effects of oral creatine supplementation on multiple sprint cycle performance. Aust J Sci Med Sport 1996;28(1):35-39
  33. Cooke WH, Barnes WS: The influence of recovery duration on high-intensity exercise performance after oral creatine supplementation. Can J Appl Physiol 1997;22(5):454-467
  34. Vanakoski J, Kosunen V, Meririnne E, et al: Creatine and caffeine in anaerobic and aerobic exercise: effects on physical performance and pharmacokinetic considerations. Int J Clin Pharmacol Ther 1998;36(5):258-262
  35. Juhn MS, Tarnopolsky M: Oral creatine supplementation and athletic performance: a critical review. Clin J Sport Med 1998;8(4):286-297
  36. Burke LM, Pyne DB, Telford RD: Effect of oral creatine supplementation on single-effort sprint performance in elite swimmers. Int J Sport Nutr 1996;6(3):222-233
  37. Javierre C, Lizarraga MA, Ventura JL, et al: Creatine supplementation does not improve physical performance in a 150 m race. Rev Esp Fisiol 1997;53(4):343-348
  38. Mujika I, Chatard JC, Lacoste L, et al: Creatine supplementation does not improve sprint performance in competitive swimmers. Med Sci Sports Exerc 1996;28(11):1435-1441
  39. Redondo DR, Dowling EA, Graham BL, et al: The effect of oral creatine monohydrate supplementation on running velocity. Int J Sport Nutr 1996;6(3):213-221
  40. Thompson CH, Kemp GJ, Sanderson AL, et al: Effect of creatine on aerobic and anaerobic metabolism in skeletal muscle in swimmers. Br J Sports Med 1996;30(3):222-225
  41. Aaserud R, Gramvik P, Olsen SR, et al: Creatine supplementation delays onset of fatigue during repeated bouts of sprint running. Scand J Med Sci Sports 1998;8(5 pt 1):247-251
  42. Bosco C, Tihanyi J, Pucspk J, et al: Effect of oral creatine supplementation on jumping and running performance. Int J Sports Med 1997;18(5):369-372
  43. Peyrebrune MC, Nevill ME, Donaldson FJ, et al: The effects of oral creatine supplementation on performance in single and repeated sprint swimming. J Sports Sci 1998;16(3):271-279
  44. Grindstaff PD, Kreider R, Bishop R, et al: Effects of creatine supplementation on repetitive sprint performance and body composition in competitive swimmers. Int J Sport Nutr 1997;7(4):330-346
  45. Cooke WH, Grandjean PW, Barnes WS: Effect of oral creatine supplementation on power output and fatigue during bicycle ergometry. J Appl Physiol 1995;78(2):670-673
  46. Odland LM, MacDougall JD, Tarnopolsky M, et al: Effect of oral creatine supplementation on muscle [Pcr] and short-term maximum power output. Med Sci Sports Exerc 1997;29(2):216-219
  47. Snow RJ, McKenna MJ, Selig SE, et al: Effect of creatine supplementation on sprint exercise performance and muscle metabolism. J Appl Physiol 1998;84(5):1667-1673
  48. United States Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Washington, DC: Dietary Supplement Health and Education Act of 1994 (DSHEA 1994: Public Law 103-417). Available at https://web.health.gov/dietsupp/toc.htm. Accessed March 26, 1999
  49. Wassertheil-Smoller S: What is involved in sample size calculation?, in Wassertheil-Smoller S: Biostatistics and Epidemiology: a Primer for Health Professionals. New York City, Springer-Verlag, 1995, pp 140-146
  50. Pritchard NR, Kalra PA: Renal dysfunction accompanying oral creatine supplements, letter. Lancet 1998;351(9111):1252-1253
  51. Koshy KM, Griswold E, Schneeberger EE: Interstitial nephritis in a patient taking creatine, letter. N Engl J Med 1999;340(10):814-815
  52. Poortmans JR, Auquier H, Renaut V, et al: Effect of short-term creatine supplementation on renal responses in men. Eur J Appl Physiol 1997;76(6):566-567
  53. Rossiter HB, Cannell ER, Jakeman PM: The effect of oral creatine supplementation on the 1000-m performance of competitive rowers. J Sports Sci 1996;14(2):175-179
  54. Moore NP, Gray TJ, Timbrell JA: Creatine metabolism in the seminiferous epithelium of rats: I. Creatine synthesis by isolated and cultured cells. J Reprod Fertil 1998;112(2):325-330
  55. Moore NP, Gray TJ, Timbrell JA: Creatine metabolism in the seminiferous epithelium of rats: II. Effect of modulators of cellular biochemical function on creatine secretion by cultured Sertoli cells. J Reprod Fertil 1998;112(2):331-336
  56. Lee HJ, Fillers WS, Iyengar MR: Phosphocreatine, an intracellular high-energy compound, is found in the extracellular fluid of the seminal vesicles in mice and rats. Proc Natl Acad Sci USA 1988;85(19):7265-7269
  57. Juhn MS, Tarnopolsky M: Potential side effects of oral creatine supplementation: a critical review. Clin J Sport Med 1998;8(4):298-304
  58. Bergnes G, Yuan W, Khandekar VS, et al: Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis. Oncol Res 1996;8(3):121-130
  59. Martin KJ, Chen SF, Clark GM, et al: Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells. J Natl Cancer Inst 1994;86(8):608-613
  60. Miller EE, Evans AE, Cohn M: Inhibition of rate of tumor growth by creatine and cyclocreatine. Proc Natl Acad Sci USA 1993;90(8):3304-3308
  61. Ohira Y, Inoue N: Effects of creatine and beta-guanidinopropionic acid on the growth of Ehrlich ascites tumor cells: i.p. injection and culture study. Biochim Biophys Acta 1995;1243(3):367-372
  62. Mihic S, MacDonald JR, McKenzie S, et al: The effect of creatine supplementation on blood pressure, plasma creatine kinase, and body composition, abstracted. Fed Am Soc Exp Biol J 1998;12(5):A652
  63. Agren H, Niklasson F: Creatinine and creatine in CSF: indices of brain energy metabolism in depression. J Neural Transm 1988;74(1):55-59
  64. Holtzman D: Brain creatine kinases and phosphocreatine: an update. Dev Neurosci 1996;18(5-6):522-523
  65. United States Food and Drug Administration, Rockville, MD: The Special Nutritionals Adverse Event Monitoring System. Available at https://vm.cfsan.fda.gov/cgi-bin/aems.cgi?QUERY=creatine&STYPE=EXACT. Accessed March 26, 1999
  66. Centers for Disease Control and Prevention: Hyperthermia and dehydration-related deaths associated with intentional rapid weight loss in three collegiate wrestlers: North Carolina, Wisconsin, and Michigan, November-December 1997. MMWR 1998;47(6):105-108


Creatine: Ethical and Medicolegal Issues

There is concern that the "win at all costs" attitude has become too prevalent in today's sports-oriented society. Adolescents are the most easily influenced age-group, yet they are the least studied with respect to sport supplementation. Regardless of whether creatine is ergogenic or not, does its prevalent use send the wrong message? Would the use of creatine and other supplements steer athletes away from the most reliable and safe method of enhancing performance, namely practice and dedicated training?

Medicolegal concerns are being addressed at the high school and college level. For example, several institutions have abandoned the practice of freely distributing creatine in training rooms for fear of potential litigation should adverse effects occur in a student-athlete. Medicolegally, physicians are advised to let athletes decide for themselves to take creatine or not. However, physicians can educate athletes to help them make informed decisions.

It should not be forgotten that although the term "athlete" is often used in sports medicine, every athlete cared for is also a patient.


Dr Juhn is an attending physician in the Family Medicine Clinic and Sports Medicine Clinic at the University of Washington's Hall Health Primary Care Center in Seattle. He is also a clinical instructor in the Department of Family Medicine at the University of Washington School of Medicine. Address correspondence to Mark S. Juhn, DO, Hall Health Primary Care Sports Medicine Center, University of Washington, Box 354410, Seattle, WA 98195-4410.


RETURN TO MAY 1999 TABLE OF CONTENTS
HOME  |   JOURNAL  |   PERSONAL HEALTH  |   RESOURCE CENTER  |   CME  |   ADVERTISER SERVICES  |   ABOUT US  |   SEARCH


The McGraw-Hill Companies Gradient

Copyright (C) 1999. The McGraw-Hill Companies. All Rights Reserved
Privacy Policy.   Privacy Notice.